The Difference Between a Telehealth Platform, Medical Group, and Pharmacy
Telehealth platform vs medical group vs pharmacy: who does what in an online GLP-1 program, and why the distinction matters for oversight and accountability.
What is the difference between a telehealth platform, a medical group, and a pharmacy?
In a typical online GLP-1 program, three roles are involved: the telehealth platform provides the technology and patient experience; the medical group (or affiliated clinicians) provides licensed medical oversight and prescribing; and the pharmacy compounds and dispenses the medication. Understanding which entity does what helps you verify licensure, oversight, and accountability.
Disclaimer: American Telehealth Review is an editorial resource and does not provide medical advice, diagnosis, or treatment. Compounded medications are not FDA-approved finished drug products and should only be prescribed when clinically appropriate by a licensed healthcare provider. Brand-name medications such as Ozempic, Wegovy, Mounjaro, and Zepbound are FDA-approved under their own applications. Compounded semaglutide and compounded tirzepatide are not FDA-approved finished drug products.
The three roles
- Platform — software, scheduling, and patient experience
- Medical group / clinicians — licensed evaluation and prescribing
- Pharmacy — compounding and dispensing (503A or 503B)
Why the distinction matters
Accountability lives with the licensed clinicians and the pharmacy, not the brand on the website. A transparent provider names its medical group and pharmacy. See 503A vs 503B and pharmacy transparency.
Frequently asked questions
Who actually prescribes my medication?
A clinician licensed in your state, affiliated with the program's medical group — not the platform brand itself.
Why should I care which pharmacy is used?
The pharmacy determines compounding oversight and quality standards; it should be named and verifiable.
Sources
- FDA — 503A pharmacies and 503B outsourcing facilities.
- Federation of State Medical Boards — Telemedicine policy resources (fsmb.org).
- U.S. FDA — Compounding and the FDA (fda.gov).